Cyclo Therapeutics (CYTH) Short Interest Ratio & Short Volume → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free CYTH Stock Alerts $1.40 +0.03 (+2.19%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cyclo Therapeutics Short Interest DataCurrent Short Volume55,300 sharesPrevious Short Volume75,300 sharesChange Vs. Previous Month-26.56%Dollar Volume Sold Short$80,738.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares28,720,000 sharesFloat Size15,960,000 sharesShort Percent of Float0.35%Today's Trading Volume21,590 sharesAverage Trading Volume90,892 sharesToday's Volume Vs. Average24% Short Selling Cyclo Therapeutics ? Sign up to receive the latest short interest report for Cyclo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCYTH Short Interest Over TimeCYTH Days to Cover Over TimeCYTH Percentage of Float Shorted Over Time Ad Stansberry ResearchA letter is coming from the "Bureau of the Fiscal Service".Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast.See if your bank is involved right here. Cyclo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202455,300 shares $80,738.00 -26.6%0.4%0.6 $1.46 4/15/202475,300 shares $93,372.00 +65.1%0.5%0.7 $1.24 3/31/202445,600 shares $63,384.00 -59.5%0.4%0.4 $1.39 3/15/2024112,600 shares $185,790.00 +77.9%0.9%1 $1.65 2/29/202463,300 shares $101,280.00 -24.0%0.6%0.7 $1.60 2/15/202483,300 shares $139,111.00 -47.6%0.8%0.9 $1.67 Get the Latest News and Ratings for CYTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024158,900 shares $300,321.00 -19.3%1.5%1.5 $1.89 1/15/2024196,800 shares $366,048.00 -40.6%1.8%2.1 $1.86 12/31/2023331,200 shares $526,608.00 +83.3%3.1%3.9 $1.59 12/15/2023180,700 shares $247,559.00 -16.7%1.7%2.3 $1.37 11/30/2023216,900 shares $312,336.00 -2.7%2.5%4 $1.44 11/15/2023223,000 shares $323,350.00 +76.4%2.6%4 $1.45 10/31/2023126,400 shares $119,448.00 -5.0%1.7%2.4 $0.95 10/15/2023133,000 shares $140,980.00 -3.1%1.3%2.6 $1.06 9/30/2023137,200 shares $194,824.00 +3.1%1.3%2.6 $1.42 9/15/2023133,100 shares $234,256.00 -31.3%1.3%2.4 $1.76 8/31/2023193,800 shares $322,677.00 -15.6%2.4%2.3 $1.67 8/15/2023229,600 shares $307,664.00 +1.7%2.8%2.5 $1.34 7/31/2023225,700 shares $349,835.00 +139.1%3.5%2.4 $1.55 7/15/202394,400 shares $137,824.00 +93.8%0.9%0.6 $1.46 6/30/202348,700 shares $77,433.00 -43.9%0.5%0.3 $1.59 6/15/202386,800 shares $183,148.00 +40.7%0.8%0.6 $2.11 5/31/202361,700 shares $74,657.00 +11.8%0.8%0.4 $1.21 5/15/202355,200 shares $58,517.52 No Change0.7%0.4 $1.06 10/31/202213,700 shares $25,893.00 +29.3%0.2%0.4 $1.89 10/15/202210,600 shares $19,080.00 -53.7%0.1%0.4 $1.80 9/30/202222,900 shares $44,197.00 +536.1%0.3%0.8 $1.93 9/15/20223,600 shares $6,948.00 +200.0%0.1%0.2 $1.93 8/31/20221,200 shares $2,544.00 -86.5%0.0%0.1 $2.12 8/15/20228,900 shares $22,072.00 +187.1%0.1%0.4 $2.48 7/31/20223,100 shares $6,107.00 +138.5%0.0%0.1 $1.97 7/15/20221,300 shares $2,782.00 -40.9%0.0%0.1 $2.14 6/30/20222,200 shares $4,334.00 -76.1%0.0%0.1 $1.97 6/15/20229,200 shares $19,320.00 +31.4%0.1%0.3 $2.10 5/31/20227,000 shares $16,100.00 +125.8%0.1%0.2 $2.30 5/15/20223,100 shares $6,541.00 -49.2%0.0%0.1 $2.11 4/30/20226,100 shares $16,348.00 -77.2%0.1%0.1 $2.68 4/15/202226,700 shares $73,692.00 -58.3%0.4%0.5 $2.76 3/31/202264,000 shares $202,880.00 +257.5%N/A1 $3.17 3/15/202217,900 shares $46,898.00 +129.5%0.2%0.3 $2.62I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look. CYTH Short Interest - Frequently Asked Questions What is Cyclo Therapeutics' current short interest? Short interest is the volume of Cyclo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 55,300 shares of CYTH short. 0.35% of Cyclo Therapeutics' shares are currently sold short. Learn More on Cyclo Therapeutics' current short interest. What is a good short interest ratio for Cyclo Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYTH shares currently have a short interest ratio of 1.0. Learn More on Cyclo Therapeutics's short interest ratio. Which institutional investors are shorting Cyclo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cyclo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cyclo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of Cyclo Therapeutics' floating shares are currently sold short. Is Cyclo Therapeutics' short interest increasing or decreasing? Cyclo Therapeutics saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 55,300 shares, a decrease of 26.6% from the previous total of 75,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cyclo Therapeutics' float size? Cyclo Therapeutics currently has issued a total of 28,720,000 shares. Some of Cyclo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclo Therapeutics currently has a public float of 15,960,000 shares. How does Cyclo Therapeutics' short interest compare to its competitors? 0.35% of Cyclo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cyclo Therapeutics: Quince Therapeutics, Inc. (6.58%), MiNK Therapeutics, Inc. (0.88%), OKYO Pharma Limited (0.43%), Estrella Immunopharma, Inc. (0.12%), Dyadic International, Inc. (0.96%), SAB Biotherapeutics, Inc. (0.30%), Achilles Therapeutics plc (0.06%), Pluri Inc. (0.97%), IN8bio, Inc. (0.60%), Brainstorm Cell Therapeutics Inc. (3.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cyclo Therapeutics stock? Short selling CYTH is an investing strategy that aims to generate trading profit from Cyclo Therapeutics as its price is falling. CYTH shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cyclo Therapeutics? A short squeeze for Cyclo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTH, which in turn drives the price of the stock up even further. How often is Cyclo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: QNCX Short Squeeze INKT Short Squeeze OKYO Short Squeeze ESLA Short Squeeze DYAI Short Squeeze SABS Short Squeeze ACHL Short Squeeze PLUR Short Squeeze INAB Short Squeeze BCLI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYTH) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap Profits